Congress moves to let stock exchanges trade cannabis company shares despite federal ban

What it does

This bill prohibits federal agencies from punishing people or businesses that provide financial, legal, accounting, real estate, or other services to cannabis companies operating legally under state law. It also creates a legal safe harbor allowing stock exchanges to list and trade securities of cannabis businesses without federal prosecution, resolving a conflict between state legalization and federal prohibition.

Why we flagged it

The bill's core mechanism is a dual deregulation: it bars federal agencies from penalizing service providers to cannabis businesses, and it creates an explicit safe harbor for securities exchanges and market participants to list and trade cannabis company securities. Both provisions remove federal enforcement risk for private parties operating in the cannabis sector.

What the text implies

• The safe harbor for securities exchanges may create a regulatory arbitrage: cannabis companies can raise capital on U.S. exchanges despite federal prohibition, potentially attracting speculative investment and complicating federal law enforcement.
• The prohibition on 'adverse action' against service providers is broadly worded ('solely because') and may shield financial institutions, insurers, and real estate firms from federal scrutiny even when their cannabis-related activities create money-laundering or sanctions-evasion risks.
• By defining 'cannabis-related legitimate business' as any entity operating under state law, the bill creates a state-federal conflict: a business legal in Colorado may be federally prosecutable, but the bill bars federal agencies from acting against its service providers.
• The 180-day effective date creates a window in which exchanges and market participants may begin listing cannabis securities before federal agencies have clarity on enforcement authority or compliance obligations.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill removes barriers to legal cannabis commerce in states where it is permitted, potentially lowering costs for cannabis businesses and their service providers while expanding market access — a benefit to consumers in those states and to legitimate businesses. However, the safe harbor for securities exchanges and market participants may enable financial speculation and regulatory arbitrage in a sector still federally prohibited, creating risks of fraud, money laundering, or market manipulat

Who stands to gain

• cannabis cultivation and retail companies
• securities exchanges and market participants
• financial services firms (banks, insurers, underwriters)
• accounting and legal service providers to cannabis industry
• real estate and equipment lessors to cannabis businesses

Named in the bill

National securities exchanges, Cannabis-related legitimate businesses, Service providers (financial, legal, accounting, real estate), Market participants (brokers, dealers, underwriters, clearing agencies), Federal agencies, State governments, Securities Exchange Act of 1934, Controlled Substances Act

Where it stands

5 cosponsors: 4 Democrats, 1 Republicans.

• Mar 18, 2026 — Introduced · Congress.gov: “Introduced in House”
• Mar 18, 2026 — Referred to House Committee on Financial Services · Congress.gov: “Referred to the House Committee on Financial Services”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

4 lobbying clients named this bill on 6 disclosure filings across 2 quarters, Mar 2026 to Jun 2026. Those filings disclosed $180,000 in lobbying spend. A filing names 4 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 72% of bills with at least one filing.

Guy Reschenthaler, the sponsor, reported $1,273,000 in PAC receipts in the 2026 cycle.

• United States Cannabis Roundtable — $90,000 on 2 filings
• The Us Cannabis Roundtable — $80,000 on 1 filing
• National Cannabis Industry Association — $10,000 on 1 filing
• Cannabis Finnancial Industry Group — $0 on 2 filings

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.